AffinityImmuno Inc. focuses on developing innovative immunotherapies that harness the power of the immune system to target and eliminate cancer cells. The company employs a proprietary platform that enables the identification and optimization of high-affinity antibodies. These antibodies are designed to enhance the immune response against tumors, providing a more effective treatment option for patients. By leveraging advanced techniques in antibody engineering, AffinityImmuno aims to create therapies that are not only potent but also have improved safety profiles.

In addition to its antibody development, AffinityImmuno is committed to advancing the understanding of immune mechanisms in cancer. The company conducts extensive research to explore the interactions between immune cells and tumor microenvironments, which is crucial for the design of effective immunotherapies. This scientific approach allows AffinityImmuno to tailor its products to meet the specific needs of different cancer types, ultimately striving to improve patient outcomes through targeted and personalized treatment strategies.

Canada

AffinityImmuno Inc. is a provider of R&D support services for your biological drug research and discovery. We specialize in antibodies, antibody lead discovery, protein engineering, and assay development for targets in cancer, autoimmune, and endocrine disorder therapeutics. 

Our goal is to help you advance your life science research through innovation and creative problem solving. Let us put our experience to work for you.

AffinityImmuno Inc.

Company Details